SWGC
GILD icon

Summit Wealth Group (Colorado)’s Gilead Sciences GILD Stock Holding History

Summit Wealth Group (Colorado)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$396K Buy
3,134
+185
+6% +$24.4K 0.03% 246
2026
Q1 		$411K Buy
+2,949
New +$413K 0.04% 203
2025
Q4 		– Sell
-7,986
Closed -$598K – 406
2025
Q3 		$598K Buy
+7,986
New +$908K 0.06% 238

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Summit Wealth Group (Colorado)'s GILD Position: Q2 2026 in Review

Summit Wealth Group (Colorado) increased its Gilead Sciences (GILD) stake by 6.3% in Q2 2026, buying an estimated $24.4K and bringing the position to 3,134 shares worth $396K. The position accounts for 0.03% of the portfolio, ranked #246.

Summit Wealth Group (Colorado) first reported a position in GILD in Q3 2025 and has held it in 3 quarters since. The position peaked at $598K in Q3 2025. 2,272 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Summit Wealth Group (Colorado) held 3,134 shares of Gilead Sciences worth $396K as of Q2 2026.
  • Summit Wealth Group (Colorado) bought 185 Gilead Sciences shares in Q2 2026, an estimated $24.4K.
  • Gilead Sciences made up 0.03% of Summit Wealth Group (Colorado)'s portfolio in Q2 2026, its #246 holding.
  • Summit Wealth Group (Colorado) first reported a position in Gilead Sciences in Q3 2025 and has held it in 3 quarters since.
  • Summit Wealth Group (Colorado)'s Gilead Sciences position peaked at $598K in Q3 2025.
  • 2,272 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Summit Wealth Group (Colorado)'s 13F filing for Q2 2026, filed 28 Jul 2026.